Hospital hears about ASA
Dr. Ayelet Erez (photo from weizmann.ac.il)
Dr. Ayelet Erez, a visiting clinician scientist from the Weizmann Institute in Rehovot, Israel, was invited to speak at B.C. Children’s Hospital earlier this month.
The group was comprised of clinicians, researchers and clinical lab scientists. The event was organized by Dr. Hilary Vallance, a Weizmann Vancouver chapter member, who is director of the B.C. Newborn Screening Program and the Biochemical Genetics Lab within the department of pathology at the hospital.
Erez gave a talk on argininosuccinic aciduria (ASA), a rare inherited disorder caused by a lack of the functional gene necessary to make an enzyme called argininosuccinate lyase. Her talk led to a discussion with members of the hospital’s metabolic division in attendance regarding various aspects of her research and how her findings could potentially improve the practice of treating patients with argininosuccinate lyase deficiency here in British Columbia.
For more information on Erez or Weizmann Canada events in Vancouver, contact Jan Goldenberg, [email protected], or call 1-855-337-9611.